Literature DB >> 23549639

Risk factors for body composition abnormalities in systemic sclerosis.

Thais F Marighela1, Patrícia de S Genaro, Marcelo M Pinheiro, Vera L Szejnfeld, Cristiane Kayser.   

Abstract

The aim of this study was to evaluate the body composition (BC), bone mineral density (BMD), and the food intake in women with systemic sclerosis (SSc) compared to a control group, in order to identify main risk factors for BC abnormalities in SSc. Sixty-one SSc women and 67 age- and gender-matched controls were included. Spine, femur, and total body BMD measurements were performed using dual-energy X-ray absorptiometry. BC measurements included total lean (LM), fat mass (FM), and relative skeletal muscle mass index (RSMI) assessment. The food intake was calculated from 3-day food records and transformed into energy and nutrients. The 61 SSc patients [30 with diffuse cutaneous disease (dcSSc) and 31 with limited cutaneous SSc (lcSSc)] had significantly lower body mass index (BMI), LM, and FM, as well as lower BMD values compared to controls. Besides, the group with dcSSc, but not those with lcSSc, showed significantly lower BC and BMD measurements than controls. There was a significant inverse correlation between disease duration and BMI, LM, and RSMI. The total energy, macronutrients, and essential amino acids intakes were similar between patients and controls. After multivariate analysis, longer disease duration was the only risk factor associated with sarcopenia (RSMI below 5.45 kg/m(2); OR = 1.36, 95% CI 1.07-1.7). The present study showed an abnormal BC and a lower BMD, especially in dcSSc women, regardless of current food intake. Longer disease duration was associated with a higher risk of sarcopenia in SSc patients.

Entities:  

Mesh:

Year:  2013        PMID: 23549639     DOI: 10.1007/s10067-013-2235-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  37 in total

1.  Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids.

Authors:  Paula Trumbo; Sandra Schlicker; Allison A Yates; Mary Poos
Journal:  J Am Diet Assoc       Date:  2002-11

Review 2.  Body composition analysis techniques in the aged adult: indications and limitations.

Authors:  Graham Woodrow
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-01       Impact factor: 4.294

Review 3.  Gastrointestinal manifestations of scleroderma.

Authors:  S Rose; M A Young; J C Reynolds
Journal:  Gastroenterol Clin North Am       Date:  1998-09       Impact factor: 3.806

4.  Systemic sclerosis and bone loss: the role of the disease and body composition.

Authors:  R B C Souza; C T L Borges; L Takayama; J M Aldrighi; R M R Pereira
Journal:  Scand J Rheumatol       Date:  2006 Sep-Oct       Impact factor: 3.641

5.  Health values of patients with systemic sclerosis.

Authors:  Dinesh Khanna; Mansoor Ahmed; Daniel E Furst; Shaari S Ginsburg; Grace S Park; Richard Hornung; Joel Tsevat
Journal:  Arthritis Rheum       Date:  2007-02-15

6.  Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis.

Authors:  J A Kanis; O Johnell; A Oden; B Jonsson; C De Laet; A Dawson
Journal:  Bone       Date:  2000-11       Impact factor: 4.398

7.  Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics".

Authors:  M Muscaritoli; S D Anker; J Argilés; Z Aversa; J M Bauer; G Biolo; Y Boirie; I Bosaeus; T Cederholm; P Costelli; K C Fearon; A Laviano; M Maggio; F Rossi Fanelli; S M Schneider; A Schols; C C Sieber
Journal:  Clin Nutr       Date:  2010-01-08       Impact factor: 7.324

8.  Home parenteral nutrition--an effective and safe long-term therapy for systemic sclerosis-related intestinal failure.

Authors:  M Brown; A Teubner; J Shaffer; A L Herrick
Journal:  Rheumatology (Oxford)       Date:  2007-12-14       Impact factor: 7.580

9.  Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?

Authors:  Katja Lakota; Jun Wei; Mary Carns; Monique Hinchcliff; Jungwha Lee; Michael L Whitfield; Snezna Sodin-Semrl; John Varga
Journal:  Arthritis Res Ther       Date:  2012-05-01       Impact factor: 5.156

10.  Nutrient intakes related to osteoporotic fractures in men and women--the Brazilian Osteoporosis Study (BRAZOS).

Authors:  Marcelo M Pinheiro; Natielen J Schuch; Patrícia S Genaro; Rozana M Ciconelli; Marcos B Ferraz; Lígia A Martini
Journal:  Nutr J       Date:  2009-01-29       Impact factor: 3.271

View more
  14 in total

1.  Body composition and bone status in relation to microvascular damage in systemic sclerosis patients.

Authors:  V Smith; M Cutolo; S Paolino; E Gotelli; F Goegan; A Casabella; G Ferrari; M Patane; M Albertelli; F Gatto; C Pizzorni; F Cattelan; A Sulli
Journal:  J Endocrinol Invest       Date:  2020-05-24       Impact factor: 4.256

Review 2.  Recent Developments in the Classification, Evaluation, Pathophysiology, and Management of Scleroderma Renal Crisis.

Authors:  Cybele Ghossein; John Varga; Andrew Z Fenves
Journal:  Curr Rheumatol Rep       Date:  2016-01       Impact factor: 4.592

Review 3.  Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulation.

Authors:  Fabiana B Benatti; Bente K Pedersen
Journal:  Nat Rev Rheumatol       Date:  2014-11-25       Impact factor: 20.543

4.  The need to accurately measure energy intake and expenditure in patients with systemic sclerosis.

Authors:  Michael Hughes; Elizabeth Harrison; Ariane L Herrick; John T McLaughlin; Simon Lal
Journal:  J Scleroderma Relat Disord       Date:  2022-05-30

5.  Sarcopenia in systemic sclerosis: the impact of nutritional, clinical, and laboratory features.

Authors:  Claudio Corallo; Antonella Fioravanti; Sara Tenti; Gianluca Pecetti; Ranuccio Nuti; Nicola Giordano
Journal:  Rheumatol Int       Date:  2019-08-01       Impact factor: 2.631

6.  A meta-analysis of fracture risk and bone mineral density in patients with systemic sclerosis.

Authors:  Juan Chen; Ling Lei; Jie Pan; Cheng Zhao
Journal:  Clin Rheumatol       Date:  2019-12-14       Impact factor: 2.980

7.  Serum adropin level and ENHO gene expression in systemic sclerosis.

Authors:  Servet Yolbas; Murat Kara; Musa Yilmaz; Suleyman Aydin; Suleyman Serdar Koca
Journal:  Clin Rheumatol       Date:  2016-04-15       Impact factor: 2.980

8.  Symptoms related to gastrointestinal tract involvement and low muscularity in systemic sclerosis.

Authors:  Edoardo Rosato; Antonietta Gigante; Chiara Pellicano; Annalisa Villa; Francesco Iannazzo; Danilo Alunni Fegatelli; Maurizio Muscaritoli
Journal:  Clin Rheumatol       Date:  2022-02-11       Impact factor: 3.650

Review 9.  Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases).

Authors:  Elisa Gremese; Barbara Tolusso; Maria Rita Gigante; Gianfranco Ferraccioli
Journal:  Front Immunol       Date:  2014-11-11       Impact factor: 7.561

Review 10.  Sarcopenia in rheumatic disorders: what the radiologist and rheumatologist should know.

Authors:  Wilfred Manzano; Leon Lenchik; Akshay S Chaudhari; Lawrence Yao; Sarthak Gupta; Robert D Boutin
Journal:  Skeletal Radiol       Date:  2021-07-16       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.